We are the link between patients with special needs and the pharmaceutical market in cases where commercial drug providers are not able to deliver what is required.
Through our owner's directive, we have been commissioned to provide extemporaneous drugs and stock preparations to provide patients with special needs with individualized drugs.
It can for example be when:
Prescription of extemporaneous drugs and stock preparations takes place in collaboration with specialist doctors, prescribers and authorities.
When the prescription of an extemporaneous drug becomes more extensive, it is called a stock preparation. Stock preparations are mass-produced, have a longer shelf life and can be delivered faster than extemporaneous drugs.
We strive to set a good example and be transparent in the context of sustainable enterprise. This is done through a continuous and open dialogue with all stakeholders, to ensure that we act in accordance with the directives and wishes presented. We are continuously working on measures that aim to reduce environmental impact and increase the effect in the value chain.